{"disease":{"id":"acute-respiratory-viral-infection","name":"acute respiratory viral infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07279298","title":"Effectiveness of Immunization in Preventing Severe Acute Respiratory Infection RSV","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1097,"lead_sponsor_name":"Bogotá District Health Secretariat","has_results":false},{"nct_id":"NCT06286254","title":"Study of Safety and Efficacy of the Drug Cycloferone in Patients with Acute Respiratory Viral Infection","phase":"","overall_status":"COMPLETED","enrollment_count":742,"lead_sponsor_name":"POLYSAN Scientific & Technological Pharmaceutical Company","has_results":false},{"nct_id":"NCT02072174","title":"Efficacy of Anaferon for Children in the Treatment of Influenza and Acute Respiratory Viral Infections in Children","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":569,"lead_sponsor_name":"Materia Medica Holding","has_results":true},{"nct_id":"NCT04476979","title":"Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":453,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04918771","title":"Clinical Study of Efficacy and Safety of Raphamin in the Treatment of ARVI in Children 12-18 Years Old","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":435,"lead_sponsor_name":"Materia Medica Holding","has_results":true},{"nct_id":"NCT03189537","title":"Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"Valenta Pharm JSC","has_results":false},{"nct_id":"NCT06715891","title":"Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of ARVI in Children Aged 3-12 Years","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":374,"lead_sponsor_name":"Materia Medica Holding","has_results":false},{"nct_id":"NCT07420985","title":"Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules (Valenta Pharm JSC) at Different Doses in Subjects With Influenza and Other Acute Respiratory Viral Infections.","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Valenta Pharm JSC","has_results":false},{"nct_id":"NCT03039621","title":"Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":287,"lead_sponsor_name":"Materia Medica Holding","has_results":true},{"nct_id":"NCT03707912","title":"Clinical Trial of Efficacy and Safety of Anaferon in the Treatment of Acute Respiratory Viral Infections","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":204,"lead_sponsor_name":"Materia Medica Holding","has_results":true},{"nct_id":"NCT04611061","title":"Kagocel® for the Prevention of ARVI and Influenza in Adults Health Care Workers","phase":"","overall_status":"COMPLETED","enrollment_count":204,"lead_sponsor_name":"Nearmedic Plus LLC","has_results":false},{"nct_id":"NCT06271655","title":"Rapid Diagnosis of Viral Acute Respiratory Infection to Decrease Unnecessary Antibiotic Utilization in the Emergency Department (RADIATE)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Christopher Payette","has_results":false},{"nct_id":"NCT04326387","title":"Evaluation of Novel Diagnostic Tests for COVID-19","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"CCTU- Cancer Theme","has_results":false},{"nct_id":"NCT05661604","title":"A Study to Investigate Acute Respiratory Virus Infections in Participants at High Risk for Severe Illness","phase":"","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT03830905","title":"Study to Assess Efficacy and Safety of XC221 200 mg in the Treatment of Influenza or Other ARVI","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"PHARMENTERPRISES LLC","has_results":false},{"nct_id":"NCT03455491","title":"Study to Assess Efficacy and Safety of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral Infections","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"PHARMENTERPRISES LLC","has_results":true},{"nct_id":"NCT04682444","title":"Efficacy and Safety of Enisamium Iodide for the Treatment of Acute Respiratory Viral Infections, Including Influenza.","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Joint Stock Company \"Farmak\"","has_results":true},{"nct_id":"NCT04822818","title":"EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":96,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04365101","title":"Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":86,"lead_sponsor_name":"Celularity Incorporated","has_results":false},{"nct_id":"NCT04626622","title":"Kagocel® for the Prevention of ARVI and Influenza in Young People","phase":"","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Nearmedic Plus LLC","has_results":false},{"nct_id":"NCT06149494","title":"RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Altesa Biosciences, Inc.","has_results":false},{"nct_id":"NCT05090475","title":"Implementation of Academic Detailing Interventions on Prescribing of Antimicrobial Drugs in Primary Health Care","phase":"NA","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"General Hospital Koprivnica","has_results":false},{"nct_id":"NCT04664075","title":"Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)","phase":"","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"Imperial College London","has_results":true}],"total":23},"guidelines":[],"source":"Drug Landscape verified database"}